Drugs / Ibuflex®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04772781 Comparator | Jun 2022 → May 2023 | — | Apsen Farmaceutica S.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ibuflex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04772781 ↗ |
| Known as | ibuprofen | “Ibuflex® - ibuprofen” NCT04772781 ↗ |